about
Cardiovascular risk in rheumatoid arthritis: assessment, management and next stepsCardiovascular comorbidity in rheumatic diseases: a focus on heart failurePathogenesis and prevention of rheumatic disease: focus on preclinical RA and SLEAssociation of hyperlipidaemia, inflammation and serological status and coronary heart disease among patients with rheumatoid arthritis: data from the National Veterans Health AdministrationAnti-nuclear autoantibodies in the general German population: prevalence and lack of association with selected cardiovascular and metabolic disorders-findings of a multicenter population-based studyAnti-carbamylated protein autoantibodies associated with mortality in Spanish rheumatoid arthritis patientsAntiphospholipid antibodies and sub-clinical atherosclerosis in the Coronary Artery Risk Development in Young Adults (CARDIA) cohort.Rheumatoid factor and anti-citrullinated protein antibody positivity, but not level, are associated with increased mortality in patients with rheumatoid arthritis: results from two large independent cohorts.Heart disease and rheumatoid arthritis: understanding the risks.Is atherosclerosis an autoimmune disease?Interleukin 17 as a novel predictor of vascular function in rheumatoid arthritisExtra-articular Manifestations in Rheumatoid Arthritis.Rheumatoid factor, anti-nuclear antibody in ischemic heart disease: Acute versus chronic patients.Systemic lupus erythematosus and systemic autoimmune connective tissue disorders behind recurrent diastolic heart failure.Rheumatoid factor, not antibodies against citrullinated proteins, is associated with baseline disease activity in rheumatoid arthritis clinical trialsRheumatoid Arthritis, Anti-Cyclic Citrullinated Peptide Positivity, and Cardiovascular Disease Risk in the Women's Health Initiative.Predictive value of antinuclear antibodies in autoimmune diseases classified by clinical criteria: Analytical study in a specialized health institute, one year follow-upAsymmetric dimethylarginine as a surrogate marker of endothelial dysfunction and cardiovascular risk in patients with systemic rheumatic diseases.Circulating Angiogenic T Cells and Their Subpopulations in Patients with Systemic Lupus Erythematosus.Is preclinical autoimmunity benign?: The case of cardiovascular disease.The Rochester Epidemiology Project: exploiting the capabilities for population-based research in rheumatic diseases.Can rheumatoid arthritis be prevented?Inflammatory and autoimmune mechanisms in the induction of atherosclerotic damage in systemic rheumatic diseases: two faces of the same coin.Atherosclerotic vascular damage and rheumatoid arthritis: a complex but intriguing link.Epidemiology of CVD in rheumatic disease, with a focus on RA and SLE.Cardiovascular safety of biologic therapies for the treatment of RA.Rheumatoid arthritis and cardiovascular diseaseAtherosclerotic vascular disease in the autoimmune rheumatologic patient.Cardiovascular comorbidity in rheumatic diseases.Association of Rheumatoid Factors With Subclinical and Clinical Atherosclerosis in African American Women: The Multiethnic Study of Atherosclerosis.Estimating the diagnostic accuracy of rheumatoid factor in UK primary care: a study using the Clinical Practice Research Datalink.Risk factors for the rapid increase in risk of acute coronary events in patients with new-onset rheumatoid arthritis: a nested case-control study.Circulating Anti-Coatomer Protein Complex Subunit Epsilon (COPE) Autoantibodies as a Potential Biomarker for Cardiovascular and Cerebrovascular Events in Patients with Obstructive Sleep Apnea.Anti-programmed cell death-1 antibody as a new serological marker for type 1 autoimmune hepatitis.Antinuclear antibodies and mortality in the National Health and Nutrition Examination Survey (1999-2004).The preclinical phase of rheumatoid arthritis: what is acknowledged and what needs to be assessed?Autonomic impairment in rheumatoid arthritis.Myocardial performance in children with autoimmune hepatitis: Doppler tissue imaging study.A role for autoantibodies in atherogenesis.Prevalence and Determinants of Peripheral Microvascular Endothelial Dysfunction in Rheumatoid Arthritis Patients: A Multicenter Cross-Sectional Study.
P2860
Q26744334-971BC041-7705-48E5-AFA6-DDDF2BF48791Q26823443-B3121159-BF25-446D-9F8E-EDBD97D0C129Q27003201-441A37B8-41FF-4116-8B4B-BC88DC5F1E98Q30885473-CE5C0A32-4309-4C58-A22A-15935AAD0EE9Q33771477-2991635C-AD26-4FE6-A2A0-4C00D0E6A290Q33865776-A852EC63-D8DD-4738-B647-7E3BB44FE8CFQ34005307-27A596B7-0DB2-444D-8116-DAFF42EA3391Q34746646-C8F72B33-3E2C-4DAC-BD49-84D75037E138Q35019085-A5467E3B-6CE1-49C8-A8A3-9B04AF09F151Q35123740-1B0E3B12-8D48-43BA-B55C-03FE28074A18Q35152141-F527F6DE-BD7E-460F-8194-E83BE6657EF1Q35154792-240BE8DF-0273-45D5-B890-4A9A2CC728DBQ35160608-71BFD3E6-79AA-4D6E-997F-606BFF2DF09DQ35224673-FAA50E99-2D07-4222-B63D-60F72E4A6CE4Q35755442-E2C4949E-AE62-4973-A2A3-28C34E4E58BDQ36001551-4E96BD5C-BECE-414E-943F-64F506AF310EQ36222405-00C00C1D-C56B-4331-A3D0-90964AFD2245Q36396428-8FBFF89F-0030-4851-80EA-A64CDF81B9DFQ36737988-70FE96AF-1FF5-46D9-A159-1208CE19281BQ36932166-3F01C8D3-5D2C-4D23-96BD-4C18A5D4DB19Q37027093-21AFE249-F2CB-49A8-9BF6-AA4228426F44Q37589108-041FF042-77EB-40B8-91EA-3A492429E2DDQ37782589-843C80C7-E660-4FB7-A4C9-79BCC36DA2A2Q37786648-434C3306-5BCE-45EC-AFBD-2E79DF1B96F8Q37883018-E546170F-27A7-4FA3-9109-93E485170A70Q37956137-D6824E19-AE43-4C23-9DDD-75D5D302A349Q38149252-8BB41996-0711-44C3-A98A-B542844B75A2Q38365624-44AB58A7-945C-4B57-AAEF-7CBE13F7FC40Q38568465-7D7EAAE8-8EBB-487E-88FE-6DE8834F9C48Q39783377-29BE7EDF-F884-42CB-8957-4D29D0CF7719Q40851421-8EFB605E-B17E-430A-9EB5-7D8BC7D18B1FQ41617609-21A12A31-2BB2-4DFD-8F22-567DA1514F2EQ41732431-B7122CE9-7922-4BC4-8101-B8DD6C2285EAQ42282781-7B89F2AA-CC64-4429-B0E9-90A727DC1B57Q42708363-5DE4312E-1E53-46E1-A116-69194880FCCBQ44071398-08464C26-43CC-4C6B-80F4-4E2AF8A59772Q46269700-88410AC9-1B36-4382-866B-5C11CEC90D4AQ46725210-80BBE59A-8897-4DBB-AFA5-1A4882C8FA3BQ47623831-C1D1952A-6E53-47C6-9D08-70A2D67178BDQ50285614-6244DFD3-39D3-471B-9FD9-23E0473FAFE1
P2860
description
2009 nî lūn-bûn
@nan
2009 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Autoantibodies and the risk of cardiovascular events.
@ast
Autoantibodies and the risk of cardiovascular events.
@en
type
label
Autoantibodies and the risk of cardiovascular events.
@ast
Autoantibodies and the risk of cardiovascular events.
@en
prefLabel
Autoantibodies and the risk of cardiovascular events.
@ast
Autoantibodies and the risk of cardiovascular events.
@en
P2093
P2860
P356
P1476
Autoantibodies and the risk of cardiovascular events.
@en
P2093
Cynthia S Crowson
Hilal Maradit Kremers
Kimberly P Liang
Melissa R Snyder
Sherine E Gabriel
Terry M Therneau
Veronique L Roger
P2860
P304
P356
10.3899/JRHEUM.090188
P407
P577
2009-10-15T00:00:00Z